SALIOGEN THERAPEUTICS
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders. Its Gene Coding approach is guided by our Exact DNA Integration Technology (EDIT) platform, a genome engineering technology that leverages proprietary mammal-derived enzymes they call Saliogase. With broad applicability, non-viral delivery capabilities of any size gene, and significant manufacturing advantages, EDIT has the potential to transform the treatment paradigm for inherited disorders and beyond.
SALIOGEN THERAPEUTICS
Industry:
Biotechnology Genetics Life Science Therapeutics
Founded:
2020-01-01
Address:
Burlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.saliogen.com
Total Employee:
11+
Status:
Active
Contact:
(650) 906-9468
Total Funding:
135 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Ray Therapeutics
Ray Therapeutics is a biotech company developing optogenetic gene therapies for patients with blinding diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
SymBiosis LLC
SymBiosis LLC investment in Series B - SalioGen Therapeutics
D1 Capital Partners
D1 Capital Partners investment in Series B - SalioGen Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - SalioGen Therapeutics
Retinal Degeneration Fund
Retinal Degeneration Fund investment in Series B - SalioGen Therapeutics
GordonMD Global Investments
GordonMD Global Investments investment in Series B - SalioGen Therapeutics
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Series B - SalioGen Therapeutics
T. Rowe Price
T. Rowe Price investment in Series B - SalioGen Therapeutics
EPIQ Capital Group
EPIQ Capital Group investment in Series B - SalioGen Therapeutics
PBM Capital Group
PBM Capital Group investment in Series A - SalioGen Therapeutics
Official Site Inspections
http://www.saliogen.com
- Host name: 104.21.62.15
- IP address: 104.21.62.15
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SalioGen Therapeutics"
SalioGen Therapeutics - Crunchbase Company Profile …
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»
SalioGen Therapeutics - 2025 Company Profile - Tracxn
SalioGen Therapeutics is a series B company based in United States, founded in 2019 by Joseph J Higgins. It operates as a Provider of gene editing platform for cell and gene therapies for …See details»
SalioGen Therapeutics - Overview, News & Similar companies
View SalioGen Therapeutics (www.saliogen.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
SalioGen Therapeutics Company Profile - Craft
SalioGen Therapeutics is a company developing genetic medicine for patients with inherited disorders. It uses a genetic modification approach that works by adding a new genomic code …See details»
SalioGen Therapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for SalioGen Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Saliogen Therapeutics - Products, Competitors, Financials, …
About Saliogen Therapeutics Saliogen Therapeutics is a biotechnology company focused on advancing genetic medicine through its innovative Gene Coding technology. The company's …See details»
SalioGen Therapeutics Company Overview, Contact Details
Jan 5, 2022 SalioGen Therapeutics Biotechnology Research Massachusetts, United States 51-200 Employees SalioGen Therapeutics is a biotechnology company on a mission to accelerate …See details»
SalioGen Therapeutics
SalioGen Therapeutics Thank you for visiting the website for SalioGen Therapeutics (“Company”), a next-generation genetic medicine company formerly based in Lexington, MA. The Company is no longer operating. Any questions …See details»
Company: SalioGen Therapeutics - CRISPR Medicine
SalioGen Therapeutics is a biotechnology company that focuses on developing advanced gene therapy solutions. They specialise in a proprietary platform called Gene Coding™, which aims …See details»
SalioGen Therapeutics Company Profile | Management and
Find contact information for SalioGen Therapeutics. Learn about their Research & Development, Business Services market share, competitors, and SalioGen Therapeutics's email format.See details»
SalioGen Therapeutics - VentureRadar
"SalioGen, The Gene Coding Company™, is advancing a new category of genetic medicine we call Gene Coding™. Gene Coding, a genetic modification approach, works by adding a new …See details»
SalioGen Therapeutics - workinbiotech.com
SalioGen Therapeutics is advancing potentially curative therapies using a new category of genetic medicines called Gene Coding. Gene Coding involves adding new genetic code to turn on, off …See details»
SalioGen Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Jun 15, 2025 Explore SalioGen Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 16 news, and 1 literature, Disease Domain:Nervous System Diseases, …See details»
SalioGen Therapeutics - News & Analysis - Crunchbase
Nov 11, 2024 SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»
SalioGen Therapeutics Overview | SignalHire Company Profile
SalioGen Therapeutics is a biotechnology company on a mission to accelerate the impact of genetic medicine for patients using its novel Gene Coding™ technology. Gene Coding is a non …See details»
SalioGen Therapeutics Closes $115 Million Oversubscribed Series B ...
CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — SalioGen Therapeutics, a privately held biotechnology company developing Gene Coding™, a new category of genetic medicine, …See details»
SalioGen Therapeutics Strengthens its Leadership Team to
Jul 20, 2022 SalioGen Therapeutics has launched Gene Coding TM, a genetic medicine platform, to develop durable, broadly applicable genetic medicines, using its Exact DNA …See details»
SalioGen Therapeutics - Funding, Financials, Valuation & Investors
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.See details»
SalioGen - SymBiosis Capital Management
SalioGen Therapeutics has launched Gene CodingTM, a genetic medicine platform, to develop durable, broadly applicable genetic medicines, using its Exact DNA Integration Technology™ …See details»
SalioGen Therapeutics | LinkedIn
SalioGen Therapeutics | 2,093 followers on LinkedIn. Gene Therapy—Evolved. The Gene Coding Company. | SalioGen is advancing a new category of genetic medicine we call Gene Coding, …See details»